Optics Technology Holding (300489.SZ) appoints Zhu Shibin as general manager
Guangzhi Technology (300489.SZ) announced that the company recently received the written resignation of its director and general manager, Mr. Liu Liuxian.
Optics Technology Holding (300489.SZ) announced that it has recently received a written resignation report from its director and general manager, Mr. Liu Liuyan. Due to work adjustment reasons, Mr. Liu Liuyan has applied to resign from his positions as director and general manager of the company, as well as resigning from the Strategic Committee of the fifth board of directors and all positions held in subsidiary companies. Mr. Liu Liuyan will not hold any other positions in the company or its subsidiaries after his resignation.
On December 26, 2024, the company held the 21st meeting of the fifth board of directors, and approved the resolution on appointing Mr. Zhu Shibin as the company's general manager. Nominated by the chairman of the board of directors and passed the qualification review of the nomination committee, the board of directors agreed to appoint Mr. Zhu Shibin as the company's general manager, relieving him of his position as deputy general manager, with a term from the date of the approval of this board meeting until the end of the term of the fifth board of directors.
Related Articles

HK Stock Market Move | ZCZL Industrial Technology Group (00564) has risen over 4% recently and plans to issue convertible bonds to raise funds of up to 4.35 billion yuan for research and development in smart manufacturing.
.png)
HK Stock Market Move | SF INTRA-CITY(09699) rose more than 4%, with an expected year-on-year profit growth of no less than 80% by 2025.

HK Stock Market Move | HENLIUS (02696) rose nearly 5% in early trading. The HLX22 head-to-head K drug for gastric cancer phase III clinical trial conducted by American researchers will be successfully held.
HK Stock Market Move | ZCZL Industrial Technology Group (00564) has risen over 4% recently and plans to issue convertible bonds to raise funds of up to 4.35 billion yuan for research and development in smart manufacturing.

HK Stock Market Move | SF INTRA-CITY(09699) rose more than 4%, with an expected year-on-year profit growth of no less than 80% by 2025.
.png)
HK Stock Market Move | HENLIUS (02696) rose nearly 5% in early trading. The HLX22 head-to-head K drug for gastric cancer phase III clinical trial conducted by American researchers will be successfully held.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


